David M. Thomas - Publications, H-index & Citations

Back

David M. Thomas

Garvan Institute of Medical Research

76H-index

608Paper Count

2.4WCitation Count

Published Papers 160

Publication Date

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program

Future Oncology

IF2.6

2026-06-16

OAAI

Derrick H. W. Siu; Frank P. Y. Lin; David M. Thomas; Subotheni Thavaneswaran; David Espinoza; Sarah Chinchen; Mandy L. Ballinger; R. John Simes; Chee Khoon Lee

Save

Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results

Psycho-Oncology

IF3.5

2026-04-23

OAAI

Megan C. Best; Joseph Descallar; Grahame Simpson; Christine E. Napier; Nicci Bartley; Mandy L. Ballinger; David Goldstein; David M. Thomas; Katherine M. Tucker; Phyllis Butow

Save

Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature

Hereditary Cancer in Clinical Practice

IF2.4

2026-03-01

PREAI

Dwarte, Tanya M.; Alli, Rozanna; Srinivasa, Shweta; Noon, Fallon; Kimmantudawage, Sumudu Perera; Gordon, Lisa; Beshay, Victoria; Joshua, Anthony M.; Araujo, Raquel Ruiz; Jalilian, Chris; Thomas, David M.; Smith, Miriam J.; Winship, Ingrid; Ballinger, Mandy L.; Li, Minmin; Tucker, Katherine M.; Courtney, Eliza K.

Save

A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations

Nature Communications

IF15.7

2026-02-10

PREAI

Jaratlerdsiri, Weerachai; Soh, Pamela X. Y.; Gong, Tingting; Jiang, Jue; Simayi, Zolani; Petersen, Desiree C.; Holland, Errol; Chan, Eva K. F.; Theron, Kathrine E.; Haacke, Wilfrid H. G.; Fortsch, Hagen E. A.; Bornman, M. S. Riana; Thomas, David M.; Mphahlele, Jeffrey; Hayes, Vanessa M.

Save

PATH-52. Understanding the prevalence ofMTAP andCDKN2A/B deletion in gliomas by next generation sequencing

Neuro-Oncology

IF13.4

2025-11-11

OAAI

Natalie Southi; Hao-Wen Sim; John Grady; Laveniya Satgunaseelan; Min Huang; Maya Kansara; Alexander Yuile; Ashraf Zaman; Frank Lin; Helen Wheeler; Amanda Hudson; Mandy L Ballinger; David M Thomas; Subotheni Thavaneswaran

Save

Implementation of precision medicine in treating non-communicable diseases: a systematic review

Journal of Translational Medicine

IF7.5

2025-10-28

OAAI

Shuang Liang; Elizabeth Kennedy; Nyree Gale; Paul Watson; Mahitha Ramanathan; Arya Shinde; Skye McKay; Andrea Torres-Robles; Zhicheng Li; Jeffery Chan; Helen Jones; Mandy L. Ballinger; Phyllis Butow; David Goldstein; Kathryn Leaney; Sandy Middleton; April Morrow; David M. Thomas; Kathy M. Tucker; Milita Zaheed; Bonny Parkinson; Frank Lin; Natalie Taylor

Save

Real-world characteristics and survival outcomes of patients with metastatic ALK fusion-positive solid tumors treated with standard-of-care therapies

ONCOLOGIST

IF4.2

2025-05-08

OAAI

Gadgeel, Shirish M.; Fajardo, Otto; Barlesi, Fabrice; Kim, Jeong Eun; Kurzrock, Razelle; Thomas, David M.; Jagtiani, Ritika; Noe, Johannes; Schwemmers, Sven; Nikolaidis, Christos

Save

Genetic predisposition in sarcomas: clinical implications and management

ECLINICALMEDICINE

IF10

2025-05-01

PREAI

Connolly, Elizabeth A.; Boye, Kjetil; Bonvalot, Sylvie; Kratz, Christian P.; Leithner, Andreas; Malkin, David; Messiou, Christina; Miah, Aisha B.; Pantziarka, Pan; Timmermann, Beate; van der Graaf, Winette T. A.; Thomas, David M.; Stacchiotti, Silvia

Save

Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular Screening and Therapeutics (MoST) program

SURGERY

IF2.7

2025-01-01

PREAI

Novis, Elan; Glover, Anthony; Grady, John P.; Silvestri, Audrey; Thavaneswaran, Subotheni; Lin, Frank; Ballinger, Mandy L.; Thomas, David M.

Save

Precision Oncology: A Global Perspective on Implementation and Policy Development

JCO GLOBAL ONCOLOGY

IF3

2025-01-01

OAAI

Horgan, Denis; Tanner, Marcel; Aggarwal, Charu; Thomas, David; Grover, Surbhi; Basel-Salmon, Lina; Dienstmann, Rodrigo; Tan, Tira Jing Ying; Park, Woong-Yang; Abu Rasheed, Hadi Mohamad; Siu, Lillian L.; Ma, Brigette; Ortiz-Lopez, Rocio; van den Bulcke, Marc; Taucher, Silvia Castillo; Ferris, Andrea; Starling, Naureen; Malapelle, Umberto; Longshore, John; Saldana, Hugo Alberto Barrera; Subbiah, Vivek

Save

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting (vol 8, 14607, 2017)

NATURE COMMUNICATIONS

IF15.7

2024-12-04

OAAI

Takeda, Kazuyoshi; Nakayama, Masafumi; Hayakawa, Yoshihiro; Kojima, Yuko; Ikeda, Hiroaki; Imai, Naoko; Ogasawara, Kouetsu; Okumura, Ko; Thomas, David M.; Smyth, Mark J.

Save

Connecting the changing trace elements spectrum and survival in sarcoma: a pilot study

METABOLOMICS

IF3.3

2024-11-09

PREAI

Collet, Laetitia; Telouk, Philippe; Albarede, Francis; Girodet, Magali; Maqua, Clemence; Rogasik, Muriel; Ducimetiere, Francoise; Tabone-Eglinger, Severine; Brahmi, Mehdi; Dufresne, Armelle; Thomas, David M.; Ballinger, Mandy L.; Blay, Jean-Yves; Ray-Coquard, Isabelle

Save

A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation

NPJ PRECISION ONCOLOGY

IF8

2024-09-09

OAAI

Thavaneswaran, Subotheni; Lin, Frank; Grady, John P.; Espinoza, David; Huang, Min Li; Chinchen, Sarah; Sebastian, Lucille; Kansara, Maya; Mersiades, Tony; Lee, Chee Khoon; Desai, Jayesh; Grimison, Peter; Brown, Michael; Millward, Michael; Harrup, Rosemary; O'Byrne, Ken; Nagrial, Adnan; Craft, Paul; Simes, John; Joshua, Anthony M.; Thomas, David M.

Save

Criteria for assessing evidence for biomarker-targeted therapies in rare cancers-an extrapolation framework

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2024-09-02

OAAI

Cho, Doah; Lord, Sarah J.; Ward, Robyn; Ijzerman, Maarten; Mitchell, Andrew; Thomas, David M.; Cheyne, Saskia; Martin, Andrew; Morton, Rachael L.; Simes, John; Lee, Chee Khoon

Save

Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Pitiyarachchi, O.; Lin, F. P.; Spooner, A.; Sharbeen, G.; Barker, H. P.; Thornton, K.; Collignon, E.; Ballinger, M. L.; Thomas, D. M.; Magenau, A.; Porazinski, S.; Raina, A.; Sjoquist, K. M.; Chantrill, L. A.; Gebski, V.; Sowmya, A.; Timpson, P.; Pajic, M.; Goldstein, D.; Phillips, P. A.

Save

Belvarafenib in patients (pts) with BRAF class II or III alteration-positive tumours: TAPISTRY study

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Dziadziuszko, R.; Damian, S.; Gadgeel, S.; Garralda, E.; Italiano, A.; Kim, J. E.; Krzakowski, M.; Lin, C-C.; Popovtzer, A.; Thomas, D.; Kirschbrown, W.; Patel, S.; Pham, T.; Sbirnac, M.; Wu, F.; Barlesi, F.

Save

Phase II trial of vemurafenib (VEM) and cobimetinib (COB) in BRAF V600-mutated solid tumours and first-line (1L) non-small cell lung cancer (NSCLC): Australian molecular screening and therapeutics (MoST) substudy 12

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Lin, F. P.; Mersiades, A.; Lee, J.; Xu, W.; Chinchen, S.; Charakidis, M.; Thavaneswaran, S.; Hughes, B. G. M.; Underhill, C. R.; Takhar, H. S.; Harrup, R.; Nagrial, A.; Millward, M.; Desai, J.; Espinoza, D.; Lee, C. K.; Solomon, B. J.; Simes, J.; Pavlakis, N.; Thomas, D.

Save

Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-04-17

OAAI

Walpole, Imogen R.; Zaman, Farzana Y.; Zhao, Peinan; Marshall, Vikki M.; Lin, Frank P.; Thomas, David M.; Shackleton, Mark; Antolin, Albert A.; Ameratunga, Malaka

Save

Trastuzumab emtansine in patients (pts) with HER2 mutation-positive (HER2mut) tumors: TAPISTRY study

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Kim, Jeong Eun; Thomas, David; Gadgeel, Shirish; Corassa, Marcelo; Tan, Tira J.; Girda, Eugenia; Richards, Donald; Tejpar, Sabine; Chen, David; Fang, Junhan; Patel, Sid; Wilson, Timothy R.; Barlesi, Fabrice

Save

Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Mirabello, Lisa; Egolf, Laura E.; Zhu, Bin; Gianferante, D. Matthew; Wang, Kevin; Li, Shengchao Alfred; Machiela, Mitchell J.; Spector, Logan G.; Schiffman, Joshua D.; Sabo, Aniko; Renwick, Alexander; Martin-Giacalone, Bailey; Scheurer, Michael E.; Plon, Sharon; Hawkins, Douglas; Venkatramani, Rajkumar; Stewart, Douglas; Morton, Lindsay M.; Hudson, Melissa M.; Armstrong, Gregory T.; Bhatia, Smita; Dean, Michael; Janeway, Katherine A.; Patino-Garcia, Ana; Lecanda, Fernando; Serra, Massimo; Hattinger, Claudia; Scotlandi, Katia; Flanagan, Adrienne M.; Amary, Fernanda; Andrulis, Irene L.; Wunder, Jay S.; Ballinger, Mandy L.; Thomas, David M.; Delattre, Olivier; Hubbard, Aubrey K.; Liu, Jia; Luo, Wen; Hicks, Belynda D.; Yeager, Meredith; Rafati, Maryam; Huang, Wen-Yi; Landi, Maria T.; Lori, Adriana; Diver, Ryan; Savage, Sharon A.; Chanock, Stephen J.; Lupo, Philip J.

Save

Research Directions